High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease -

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
Information type: Other primary research
Source: Journal of the American College of Cardiology
Specialities: Cardiovascular system disorders
Summary
Study (n=3318 men) found troponin was an independent predictor of myocardial infarction or death from CHD (HR 2.3; 95% CI 1.4-3.7) for the highest (≥5.2 ng/l) vs. lowest (≤3.1 ng/l) quarter of troponin (p< 0.001).Study also found that troponin is reduced by statin therapy.
UKMi comment
Editorial discusses the potential for the use of high sensitivity troponin assays in evaluating the long term risk of cardiovascular comorbidities. Currently NICE practice recommends the use of high sensitivity troponin tests in the acute setting when patients present with chest pain.
Related links: Editorial NICE guideline CG95